Expertise in
2
conditions

Elena Sevillano

San Sebastian, PV, ES 
Expertise in
2
conditions
San Sebastian, PV, ES 

Overview

Elena Sevillano practices practicing medicine in San Sebastian, Spain.

Ms. Sevillano is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Febrile Neutropenia, Agranulocytosis, Vaginal Yeast Infection, and Vulvovaginitis.

She is actively involved in clinical research, co-authoring 35 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

San Sebastian, PV 20018, Spain
Other Locations
Bilbao, PV 48080, Spain
Leioa, PV 48940, Spain
Madrid, MD, Spain
Palma, PM, Spain
Bizkaia, PV, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer (Study ATEZOBLADDERPRESERVE)
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer (Study ATEZOBLADDERPRESERVE)
Enrollment Status: Active_not_recruiting
Publish Date: October 26, 2022
Intervention Type: Radiation, Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
View 1 Less Clinical Trial

35 Total Publications

Lipid-Based Drug Delivery Systems as Emerging Tools to Overcome Antifungal Resistance.
Lipid-Based Drug Delivery Systems as Emerging Tools to Overcome Antifungal Resistance.
Journal: International journal of molecular sciences
Published: April 01, 2026

Frequently Asked Questions about Elena Sevillano

Is Elena Sevillano a top-rated expert for Febrile Neutropenia?

MediFind is an objective health platform that identifies experts based on real-world data. Elena Sevillano is classified as an Distinguished expert for Febrile Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Elena Sevillano participate in research or clinical trials?

Yes. Elena Sevillano has published 35 articles and abstracts on conditions like Febrile Neutropenia. You can view a list of Elena Sevillano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sevillano's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile